Abstract
Prenatal diagnosis of the hemoglobinopathies has been increasingly reported. This article discusses those ethical issues stemming from pregnancy studies by fetoscopy or placental aspiration: diagnostic accuracy and safety for mother and fetus, abortion of the fetus diagnpsed as homozygous for thalassemia or sickle cell disease, and access to prenatal diagnosis for those who cannot afford it. The author’s position on these issues attempts to mediate between the poles in current ethical debate on abortion in public policy
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call